Join the Way That Suits You Best! Attend In-Person in Jeddah, Saudi Arabia, or Virtually from Anywhere in the World!

Speaker Details

  • Home
  • Adriana Botezatu
team member image

Adriana Botezatu

Nicolae Testemitanu SUMPh of Republic of Moldova

My name is Adriana Botezatu (07.12.1985) and I have been dedicated to the development of internal medicine, gastroenterology and geriatrics, medical education and scientific research. This resume aims to reflect my extensive career path and my passion for preserving and strengthening health. I started my career in medicine as an assistant professor in "Nicolae Testemitanu" University of Medicine and Pharmacy of the Republic of Moldova I have also been active in promoting scientific research and I have published more than 40 publications, monographs and methodical elaborations. In 2021 I took PhD, now I am Associate Professor and I am interesting in post-PhD. In addition to the extensive experience in medicine, I attended multiple refresher courses and trainings in Italy (2016), Romania (2017 – 2018) and Republic of Moldova. These courses covered various aspects of medicine, including endoscopic surgery, digestive surgery and hospital management. They have significantly added value to my medical knowledge and practical skills. I am determined to continue to contribute to the well-being of patients and the progress of the medical field.

Republic of Moldova
Abstracts
2024
GASTRIC CANCER RISK IN PATIENTS WITH CHRONIC ATROPHIC GASTRITIS

The analysis of the correlation between the severity of gastric mucosal damage in chronic atrophic gastritis, determined endoscopically, and the stage of gastric mucosal atrophy and intestinal metaplasia, established according to OLGA and OLGIM staging systems, found that with the increase in the severity of chronic atrophic gastritis, the severity of the stages of the OLGA system and the OLGIM system increases. There is a direct, moderate and statistically significant correlation between forms of chronic atrophic gastritis and OLGA stages (ρ = 0.6, p <0.001), a direct, weak and statistically significant correlation between forms of chronic atrophic gastritis and OLGIM stages (ρ = 0.3, p <0.001).
A statistically significant and significant reduction of PG-I and PGR was determined simultaneously with the increase of the OLGA and OLGIM systems stages. The OLGA and OLGIM staging systems classify patients with chronic atrophic gastritis into stages with a high risk of developing gastric cancer, they are the most reliable and powerful systems that allow the recognition of the patient with a higher risk of developing gastric cancer, but their implementation is limited.
Conclusions: The implementation of OLGA and OLGIM systems for the classification and approach of chronic gastritis in medical practice is necessary to minimize the incidence and mortality rates caused by gastric cancer - a condition with an increased frequency. By applying these stratification systems for chronic atrophic gastritis, patients could benefit from appropriate treatment started in a premalignant stage.

Featured 2025 Speakers

Speakers of The Club

team member image
Prof. Dorota Zarebska-Michaluk
Vice-President - Polish Association for the Study of the Liver
team member image
Prof. Hwoon-Yong Jung
Asan Medical Center, University of Ulsan College of Medicine
team member image
Omar Khokhar
University of Illinois College of Medicine-Peoria
team member image
Feng Zhang
Department of Surgery, Klinikum rechts der Isar, School of Medicine, Technical University of Munich
team member image
Dr. Geesala Ramasatyaveni
Research Scientist, Stem Cell Biology, Gut Physiology - The University of Texas Medical Branch
team member image
Dr. Manar Fartmissi
Gastroenterology Department, Ibn Rochd University Hospital Center
team member image
Dr. Aren Nersisyan
Gastro Clinic
team member image
Dr. Alia Abdalla Ibrahim
Al Habib Hospital
team member image
Dr. Tahiri Yasmin
University Hospital Ibn Rochd of Casablanca
vector vector vector
WhatsApp Click to Chat